Breast Cancer Screening

Breast Cancer Screening

Global Breast Cancer Screening Market to Reach $8.3 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Breast Cancer Screening estimated at US$5.6 Billion in the year 2022, is projected to reach a revised size of US$8.3 Billion by 2030, growing at aCAGR of 5.1% over the period 2022-2030. Imaging Test, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$4.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunohistochemistry Test segment is readjusted to a revised 4.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 8% CAGR
The Breast Cancer Screening market in the U.S. is estimated at US$1.5 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.Select Competitors (Total 42 Featured) - A&G Pharmaceutical, Inc.Agendia NVBiocrates Life Sciences AGHologic, Inc.Metabolomic Technologies Inc.Myriad Genetics, Inc.Quest Diagnostics, Inc.Roche DiagnosticsPlease note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.